Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
Martin J Swaans, Lisette IS Wintgens, Arash Alipour, Benno JWM Rensing, Lucas VA Boersma Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands Abstract: Atrial fibrillation (AF) is the most common arrhythmia treated in the clinical practice...
Guardado en:
Autores principales: | Swaans MJ, Wintgens LIS, Alipour A, Rensing BJWM, Boersma LVA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed823a8e7f95473ea469f7adf5ad2ff8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Toshiaki Isogai, et al.
Publicado: (2021) -
Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020) -
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu Yaowu, et al.
Publicado: (2021) -
Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion
por: Liu B, et al.
Publicado: (2021) -
Patient-specific flow simulation analysis to predict device-related thrombosis in left atrial appendage occluders
por: Jordi Mill, et al.
Publicado: (2021)